TNFRSF1B and metastatic malignant neoplasm in the lymph nodes: No statistical differences were discovered between the proportion of TNFR2+Tregs and other clinicopathological factors, including lymph node metastasis, tumor size, tumor differentiation, age, and lymphovascular invasion, in patients with CC.